D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$638M |
| 2 |
NVIDIA
NVDA
|
+$461M |
| 3 |
EQT Corp
EQT
|
+$400M |
| 4 |
Citigroup
C
|
+$369M |
| 5 |
CELG
Celgene Corp
CELG
|
+$339M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$694M |
| 2 |
Dell
DELL
|
+$486M |
| 3 |
IBM
IBM
|
+$341M |
| 4 |
Amgen
AMGN
|
+$306M |
| 5 |
Johnson & Johnson
JNJ
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.05% |
| 2 | Healthcare | 10.49% |
| 3 | Consumer Discretionary | 10.21% |
| 4 | Financials | 8.38% |
| 5 | Industrials | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Mueller Water Products
MWA
$3.92B
| $420K | ﹤0.01% |
38,673
+8,908
| +30% | +$103K |
|
|
KRA
2927
DELISTED
Kraton Corporation
KRA
| $417K | ﹤0.01% |
8,747
-44,291
| -84% | -$2.14M |
|
2928
Mammoth Energy Services
TUSK
$132M
| $413K | ﹤0.01% |
+12,887
| New | +$322K |
|
2929
Independent Bank
INDB
$4.05B
| $412K | ﹤0.01% |
+5,758
| New | +$414K |
|
2930
Accenture
ACN
$89.9B
| $410K | ﹤0.01% |
2,668
-1,281
| -32% | -$203K |
|
2931
Digimarc Corp
DMRC
$133M
| $410K | ﹤0.01% |
17,133
+6,383
| +59% | +$195K |
|
2932
Fox Factory Holding Corp
FOXF
$776M
| $409K | ﹤0.01% |
11,722
+2,741
| +31% | +$104K |
|
2933
MediciNova
MNOV
$65M
| $407K | ﹤0.01% |
+34,908
| New | +$348K |
|
|
FCRD
2934
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $407K | ﹤0.01% |
52,388
-22,983
| -30% | -$196K |
|
2935
CALL
Cummins
CMI
$91.7B
| $405K | ﹤0.01% |
2,500
-53,600
| -96% | -$9.21M |
|
2936
CALL
Enanta Pharmaceuticals
ENTA
$372M
| $405K | ﹤0.01% |
+5,000
| New | +$385K |
|
|
DMC
2937
Del Monte Corp
DMC
$1.35B
| $405K | ﹤0.01% |
+8,955
| New | +$422K |
|
2938
Movado Group
MOV
$812M
| $405K | ﹤0.01% |
10,539
-1,556
| -13% | -$49.7K |
|
|
SPIL
2939
DELISTED
Siliconware Precision Industries Co Ltd
SPIL
| $405K | ﹤0.01% |
+46,866
| New | +$400K |
|
2940
Pathward Financial
CASH
$1.81B
| $404K | ﹤0.01% |
11,103
-2,571
| -19% | -$91.9K |
|
2941
Upbound Group
UPBD
$1.19B
| $404K | ﹤0.01% |
46,805
+5,770
| +14% | +$55.4K |
|
2942
Applied Industrial Technologies
AIT
$12.8B
| $403K | ﹤0.01% |
5,525
-22,669
| -80% | -$1.63M |
|
|
CRHM
2943
DELISTED
CRH Medical Corporation
CRHM
| $403K | ﹤0.01% |
159,400
+70,400
| +79% | +$197K |
|
|
CIO
2944
DELISTED
City Office REIT
CIO
| $402K | ﹤0.01% |
34,774
-50,304
| -59% | -$573K |
|
2945
CALL
Illumina
ILMN
$29.4B
| $402K | ﹤0.01% |
+1,748
| New | +$401K |
|
|
QADA
2946
DELISTED
QAD Inc.
QADA
| $402K | ﹤0.01% |
9,662
-183
| -2% | -$7.82K |
|
|
BFX
2947
DELISTED
BowFlex Inc.
BFX
| $401K | ﹤0.01% |
29,836
+3,300
| +12% | +$41.8K |
|
|
EGRX
2948
PUT
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $400K | ﹤0.01% |
7,600
-400
| -5% | -$23.3K |
|
2949
Avanos Medical
AVNS
$1.17B
| $399K | ﹤0.01% |
8,650
-14,638
| -63% | -$695K |
|
2950
Teladoc Health
TDOC
$1.58B
| $399K | ﹤0.01% |
+9,896
| New | +$374K |
|
Similar funds
D.E. Shaw & Co's Q1 2018 Portfolio in Review
As of Q1 2018, D.E. Shaw & Co held 3,998 positions worth $73.5B, up 1.2% from $72.6B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co's Q1 2018 filing shows 451 new, 1,293 increased, 1,502 reduced and 554 closed positions. Its largest new stake was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M. The largest sale was Meta Platforms (Facebook), an estimated $694M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M.
- D.E. Shaw & Co added most to Lowe's Companies in Q1 2018, an estimated $638M increase.
- D.E. Shaw & Co's biggest Q1 2018 reduction was Meta Platforms (Facebook), cutting an estimated $694M.
- D.E. Shaw & Co fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q1 2018, selling an estimated $141M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $73.5B portfolio in Q1 2018.
- D.E. Shaw & Co opened 451 new positions and closed 554 in Q1 2018.
- D.E. Shaw & Co's portfolio value rose 1.2% quarter-over-quarter to $73.5B.
Based on D.E. Shaw & Co's 13F filing for Q1 2018, filed 15 May 2018.